AGP Picks
View all

America Latina Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.

Press releases published on June 9, 2026

'Chanting River', del artista John Francis Peters: 'Una pintura que primero se escucha'
TIGHITCO EXPANDS SUPPORT OF BOMBARDIER BUSINESS JET PLATFORMS WITH LATEST MHICA AWARD
Branching Minds Named to Fortune’s Best Workplaces in New York™ List for the Second Consecutive Year
Sitestream Wins Five-Year, Automated Traffic Enforcement SaaS Contract with Kirtland Hills, Ohio
Rock Pest Control Launches Summer Bed Bug Giveaway as Kansas City Prepares for World Cup Travel Surge
1 Percent Lists Partners with One Click SEO to Offer Franchises 90 Days of Free 'Agentic Tools' AI Technology
sslTrus de NicSRS registra un fuerte crecimiento de interés en el mercado durante el último año
The Social Commerce Operational Gap: Logistics as the 2026 Profitability Bottleneck
Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn’s Disease at New York Academy of Sciences Symposium
Jet.AI Announces Review of Strategic Alternatives for SpaceX Equity Interest
Sensor Bio Welcomes Dr. Michael Poku as Clinical Advisor
Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis
Linnaeus Therapeutics Announces Selection of LNS8801 into the National Institute on Aging Interventions Testing Program
Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003) 
Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long-Acting Anti-TSLP Antibody WIN378
Vaxart to Participate in BTIG Infectious Disease Day 2026
GoldHaven Closes Upsized C$5.75 Million LIFE Financing to Advance Magno and Copeçal Projects
Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma
Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China
Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine…

Share this page:

Sign up for:

America Latina Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.